Journal
MOLECULAR BIOMEDICINE
Volume 3, Issue 1, Pages -Publisher
SPRINGERNATURE
DOI: 10.1186/s43556-022-00090-3
Keywords
Vesicle formation; Vesicle transport; Vesicle fusion; Fusogenic proteins; Disease therapy
Funding
- National Natural Science Foundation of China [31900688, 32170686, 00402054A1337]
- Sichuan University [20822041D4058]
Ask authors/readers for more resources
Intracellular vesicle trafficking is essential for maintaining the homeostasis of membrane-enclosed organelles. The process involves vesicle formation, transport, and fusion with target membranes. Various proteins and factors are involved in regulating vesicle fusion, and dysfunctions in this process can contribute to diseases.
Intracellular vesicle trafficking is the fundamental process to maintain the homeostasis of membrane-enclosed organelles in eukaryotic cells. These organelles transport cargo from the donor membrane to the target membrane through the cargo containing vesicles. Vesicle trafficking pathway includes vesicle formation from the donor membrane, vesicle transport, and vesicle fusion with the target membrane. Coat protein mediated vesicle formation is a delicate membrane budding process for cargo molecules selection and package into vesicle carriers. Vesicle transport is a dynamic and specific process for the cargo containing vesicles translocation from the donor membrane to the target membrane. This process requires a group of conserved proteins such as Rab GTPases, motor adaptors, and motor proteins to ensure vesicle transport along cytoskeletal track. Soluble N-ethyl-maleimide-sensitive factor (NSF) attachment protein receptors (SNARE)-mediated vesicle fusion is the final process for vesicle unloading the cargo molecules at the target membrane. To ensure vesicle fusion occurring at a defined position and time pattern in eukaryotic cell, multiple fusogenic proteins, such as synaptotagmin (Syt), complexin (Cpx), Munc13, Munc18 and other tethering factors, cooperate together to precisely regulate the process of vesicle fusion. Dysfunctions of the fusogenic proteins in SNARE-mediated vesicle fusion are closely related to many diseases. Recent studies have suggested that stimulated membrane fusion can be manipulated pharmacologically via disruption the interface between the SNARE complex and Ca2+ sensor protein. Here, we summarize recent insights into the molecular mechanisms of vesicle trafficking, and implications for the development of new therapeutics based on the manipulation of vesicle fusion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available